The role of PCMT1 in prognosis tumor immune microenvironment and therapeutic responses across cancers
Multi-omics analysis suggests that PCMT1 may serve as a potential prognostic biomarker and a novel immunotherapy target for pan-cancer.
Authors
- Sijia Huang
- Haixia Zhao (ORCID: https://orcid.org/0009-0003-8305-6009)
- Ruiqian Yao (ORCID: https://orcid.org/0009-0007-6118-1879)
- Bo Wang
- Hao Zhu
- Ruizhen Ren
- Liangzhe Wang
- Mengyu Zhang
- Erwen Kou
- Yuanjie Zhu
Institutions
- Handan College (CN)
- Shanghai University (CN)
- Naval Medical Research Command (US)
- Shanghai Medical Information Center (CN)
- Han Dan City Eye Hospital - The Third Hospital of Handan (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1007/s12672-025-04366-2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00